Biolase, Inc.Biolase, Inc.Biolase, Inc.

Biolase, Inc.

No trades
See on Supercharts
Market capitalization
‪4.42 M‬USD
−38.0149USD
‪−20.63 M‬USD
‪49.16 M‬USD
‪31.21 M‬
Beta (1Y)
1.26

About Biolase, Inc.

CEO
John R. Beaver
Headquarters
Lake Forest
Employees (FY)
157
Founded
1984
ISIN
US0909117022
FIGI
BBG000DDG8B9
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOL is 0.14 USD — it has decreased by 0.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biolase, Inc. stocks are traded under the ticker BIOL.
Biolase, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Biolase, Inc. has a max estimate of 4.00 USD and a min estimate of 0.40 USD.
BIOL earnings for the last quarter are −3.89 USD whereas the estimation was −1.78 USD which accounts for −119.15% surprise. Estimated earnings for the next quarter are −2.56 USD. See more details about Biolase, Inc. earnings.
Biolase, Inc. revenue for the last quarter amounts to ‪10.92 M‬ USD despite the estimated figure of ‪13.21 M‬ USD. In the next quarter revenue is expected to reach ‪13.55 M‬ USD.
Yes, you can track Biolase, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BIOL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biolase, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BIOL reached its all-time high on Jan 21, 2004 with the price of 245654.95 USD, and its all-time low was 0.13 USD and was reached on Mar 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 157.00 employees. See our rating of the largest employees — is Biolase, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biolase, Inc. EBITDA is ‪−15.14 M‬ USD, and current EBITDA margin is −30.79%. See more stats in Biolase, Inc. financial statements.